 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 triphenylsulfonium 1,1-difluoro-2-((1-ox |
| (4-iodophenyl)diphenylsulfonium cyclobut |
| Acetic acid, 2,2-difluoro-2-[4-(methylsu |
| methyldiphenylsulfonium 2,3,5,6-tetraflu |
| 1-Chloroethyl adamantane-1-carboxylate |
| Chloromethyl 1-methylcyclohexanecarboxyl |
| (1,1-Dimethyl-2-propen-1-yl)trimethoxysi |
| Silane, trimethoxy(2-methyl-3-buten-1-yl |
| Silane, (1,2-dimethyl-2-propen-1-yl)trim |
| 6-Bromo-1,4-dichloroisoquinoline |
| 2-methyladamantan-2-yl 6-(methacryloylox |
| triphenylsulfonium bis(1-acetoxycyclohex |
| triphenylsulfonium 2-(adamantan-1-ylmeth |
| triphenylsulfonium 1-fluoro-2-(2-methoxy |
| 1,1′-Bis(1,1-dimethylethyl) 4,4′-(1, |
| Sulfonium, triphenyl-, 1-propanesulfonat |
| 2,2′-[(1-Methylethylidene)bis(4,1-phen |
| 2-(5-(((octylsulfonyl)oxy)imino)thiophen |
| 5-phenyl-5H-dibenzo[b,d]thiophen-5-ium 3 |
| Iodonium, diphenyl-, 2,5-dihydroxybenzen |
| 1-phenylhexahydrothiopyrylium (2,4-dihyd |
| triphenylsulfonium 4-amino-3-hydroxynaph |
| diphenyl(p-tolyl)sulfonium 2,4-diaminobe |
| Benzenesulfonamide, N-(2,4-dihydroxyphen |
| 2-methyladamantan-2-yl 4-vinyl-1-naphtho |
| PAG342 |
| methyl 3-ethoxy-1H-pyrazole-5-carboxylat |
| Ethyl 3-[[(1,1-dimethylethyl)dimethylsil |
| 5-Chloro-3-iodo-1-(tetrahydro-2H-pyran-2 |
| 1,1-Dimethylethyl 3-[6-[3-(trifluorometh |
| (3-((tert-butyldimethylsilyl)oxy)-1-meth |
| (3-((tert-butyldimethylsilyl)oxy)-4-iodo |
| ethyl 3-isopropoxy-1H-pyrazole-5-carboxy |
| ethyl 3-ethoxy-1H-pyrazole-5-carboxylate |
| 3-(2’-chloro-4’-(methylsulfonyl)-[1, |
| 5-(bromomethyl)-1-(2-((tert-butyldimethy |
| ethyl 5-((2-(trimethylsilyl)ethoxy)metho |
| 3-(4’-chloro-2’-(methylsulfonyl)-[1, |
| 2-[4-(1,1-Dimethylethyl)phenoxy]-5-nitro |
| 1,1-Dimethylethyl 3-[[2-fluoro-4-(triflu |
| 2-Pyrazinamine, 5-bromo-6-methoxy- |
| tert-butyl 3-allyl-3-aminoazetidine-1-ca |
| 5-Bromo-2-[3-(trifluoromethyl)-1-pyrroli |
| 3-(cyclopropoxymethyl)-1-methyl-1H-pyraz |
| N2,N2-dimethylpyridine-2,5-diamine trihy |
| 5-Bromo-2,3-dihydro-2-methyl-4H-1,2,3-tr |
| 6-Methoxy-3-methyl-2-pyrazinamine |
| 3-Chloro-5-methoxy-2-methylpyrazine |
| 5-Bromo-3-iodo-6-methyl-1H-pyrazolo[3,4- |
| 1,1-Dimethylethyl 3-amino-3-ethenyl-1-az |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| W38353 | PSI-6206 | 863329-66-2 | 95% |
| W38354 | PSI 6130 | 817204-33-4 | 95% |
| W38356 | [2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-(4-pyridinyl)-1H-1,2,3-triazol-4-yl]-3-pyridinyl](2-chlorophenyl)Methanone | 622370-35-8 | 95% |
| W38363 | 4-(2,3-dichlorophenyl)-5-(methoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylic acid | 123853-39-4 | 95% |
| W38705 | Cyheptamide | 7199-29-3 | 95% |
| W42125 | Fostamatinib | 901119-35-5 | 95% |
| W42150 | Benzilide | 467-32-3 | 95% |
| W42191 | TCS-1102 | 916141-36-1 | 95% |
| W42208 | Nicobifen | 188425-85-6 | 95% |
| W42305 | Lorcaserin hydrochloride | 846589-98-8 | 95% |
| W42306 | Flurbiprofen axetil | 91503-79-6 | 95% |
| W42307 | Nifuratel | 4936-47-4 | 95% |
| W42313 | Pagoclone | 133737-32-3 | 95% |
| W42314 | CL 218872 | 66548-69-4 | 95% |
| W42316 | 3-(1H-indazol-5-yl)-N-propyl-Imidazo[1,2-b]pyridazin-6-amine | 1333377-65-3 | 95% |
| W42317 | (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide | 1217486-61-7 | 95% |
| W42318 | N-(4-(2-benzoylhydrazinecarbonyl)benzyl)-3-chloro-4-fluorobenzenesulfonamide | 852918-02-6 | 95% |
| W42319 | (E)-3-(p-Toluenesulfonyl)acrylonitrile | 19542-67-7 | 95% |
| W42320 | 2-[(Biphenyl-4-yl)carbamoyl]benzoic acid | 4727-31-5 | 95% |
| W42325 | EPZ-6438 | 1403254-99-8 | 95% |
| W42326 | FK228 | 128517-07-7 | 95% |
| W42327 | AZD3514 | 1240299-33-5 | 95% |
| W42328 | EPZ-5676 | 1380288-87-8 | 95% |
| W42329 | EPZ004777 | 1338466-77-5 | 95% |
| W42330 | NSC319726 | 71555-25-4 | 95% |
| W42331 | DBEQ | 177355-84-9 | 95% |
| W42332 | EHOP-016 | 1380432-32-5 | 95% |
| W42333 | KPT-185 | 1333151-73-7 | 95% |
| W42334 | BMN-673 | 1207456-01-6 | 95% |
| W42335 | LY411575 | 1103516-01-3 | 95% |
|
|
|
|
